A Phase 1 Study of Picoplatin in Subjects With Advanced Non-Hematological Malignancies With Emphasis on Cardiac Repolarization.

Trial Profile

A Phase 1 Study of Picoplatin in Subjects With Advanced Non-Hematological Malignancies With Emphasis on Cardiac Repolarization.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jul 2009

At a glance

  • Drugs Picoplatin (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Jul 2009 Cardic safety data were reported in a Poniard Pharmaceuticals media release and will be presented at a medical conference later this year.
    • 21 Jul 2009 Status changed from active, no longer recruiting to completed, according to a Poniard Pharmaceuticals media release.
    • 17 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top